Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Abraham

Showing results (931-940 of 953) with videos related to

Pageof 96
Sort By:
Cancer Cell|December 10, 2014
Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitorCamilla L Christensen, Nicholas Kwiatkowski, Brian J Abraham, et al.
The Journal of Experimental Medicine|June 27, 2018
JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemiaMarc R Mansour, Shuning He, Zhaodong Li, et al.
Science (New York, N.Y.)|May 14, 2021
Cell-specific transcriptional control of mitochondrial metabolism by TIF1γ drives erythropoiesisMarlies P Rossmann, Karen Hoi, Victoria Chan, et al.
Scientific Reports|July 2, 2025
Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumorsJ Abraham, V Domenyuk, N Perdigones, et al.
Nature Genetics|August 23, 2016
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomasVictoria E Clark, Akdes Serin Harmancı, Hanwen Bai, et al.
Cancer Discovery|October 5, 2017
TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic LeukemiaRiadh Lobbardi, Jordan Pinder, Barbara Martinez-Pastor, et al.
Cancer Discovery|March 8, 2018
Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk NeuroblastomaPresha Rajbhandari, Gonzalo Lopez, Claudia Capdevila, et al.
Cancer Discovery|October 22, 2017
Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional RepressionMaria Rusan, Kapsok Li, Yvonne Li, et al.
Cancer Discovery|November 13, 2021
EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified NeuroblastomaAdam D Durbin, Tingjian Wang, Virangika K Wimalasena, et al.
Science Advances|November 24, 2021
Predicting master transcription factors from pan-cancer expression dataJessica Reddy, Marcos A S Fonseca, Rosario I Corona, et al.
Pageof 96

Showing results (931-940 of 953) with videos related to

Sort By:
Pageof 96
Cancer Cell|December 10, 2014
Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitorCamilla L Christensen, Nicholas Kwiatkowski, Brian J Abraham, et al.
The Journal of Experimental Medicine|June 27, 2018
JDP2: An oncogenic bZIP transcription factor in T cell acute lymphoblastic leukemiaMarc R Mansour, Shuning He, Zhaodong Li, et al.
Science (New York, N.Y.)|May 14, 2021
Cell-specific transcriptional control of mitochondrial metabolism by TIF1γ drives erythropoiesisMarlies P Rossmann, Karen Hoi, Victoria Chan, et al.
Scientific Reports|July 2, 2025
Validation of an AI-enabled exome/transcriptome liquid biopsy platform for early detection, MRD, disease monitoring, and therapy selection for solid tumorsJ Abraham, V Domenyuk, N Perdigones, et al.
Nature Genetics|August 23, 2016
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomasVictoria E Clark, Akdes Serin Harmancı, Hanwen Bai, et al.
Cancer Discovery|October 5, 2017
TOX Regulates Growth, DNA Repair, and Genomic Instability in T-cell Acute Lymphoblastic LeukemiaRiadh Lobbardi, Jordan Pinder, Barbara Martinez-Pastor, et al.
Cancer Discovery|March 8, 2018
Cross-Cohort Analysis Identifies a TEAD4-MYCN Positive Feedback Loop as the Core Regulatory Element of High-Risk NeuroblastomaPresha Rajbhandari, Gonzalo Lopez, Claudia Capdevila, et al.
Cancer Discovery|October 22, 2017
Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional RepressionMaria Rusan, Kapsok Li, Yvonne Li, et al.
Cancer Discovery|November 13, 2021
EP300 Selectively Controls the Enhancer Landscape of MYCN-Amplified NeuroblastomaAdam D Durbin, Tingjian Wang, Virangika K Wimalasena, et al.
Science Advances|November 24, 2021
Predicting master transcription factors from pan-cancer expression dataJessica Reddy, Marcos A S Fonseca, Rosario I Corona, et al.
Pageof 96